Aetiology of atherosclerosis;Etiologie de l'atherosclerose

Revue du Praticien

Volumn 49, Issue 19, 1999, Pages 2100-2103

  Capron, Loïc ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY CALCIFICATION; ATHEROSCLEROSIS; CORONARY ARTERY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; HUMAN; HYPERCHOLESTEROLEMIA; INFECTION; INFLAMMATION; MICROALBUMINURIA; NONHUMAN; REVIEW; RISK FACTOR; ARTERIOSCLEROSIS; ARTICLE; PATHOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT;

ARTERIOSCLEROSIS; HUMANS; INFECTION; INFLAMMATION; RISK ASSESSMENT;

EID: 0033485507     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-26.
2. Capron L. Mécanismes inflammatoires de l'athérosclèroses inférences pathogéniques et étiologiques. Arch Mal Cœur 1993;86 (suppl. 1): 19-30.
3. Capron L. Évolution des théories sur l'athérosclérose. Rev Prat 1996;46: 533-7.
4. Müller C. Angina pectoris in hereditary xanthomatosis. Arch Intern Med 1939; 64:675-700.
5. Gibson JB, Carson NAJ, Neill DW. Pathological findings in homocystinuria. J Clin Pathol 1964;17:427-37.
6. Hopkins PN, Williams RR.A survey of 246 suggested coronary risk factors. Atherosclerosis 1981;40:1-52.
7. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
8. Schwartz SM, Murry CE. Proliferation and the monoclonal origins of atherosclerotic lesions.Annu Rev Med 1998;49:437-60.
9. Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensammer G, Xu Q. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue.FASEB J 1997; 11:1199-207.
10. Scebat L, Groult N, Renais J.Possible intervention de mécanismes immuns dans la genèse et l'évolution de l'athérosclérose humaine. Pathol Biol 1985;33:163-8.
11. Stemme S, Rymo L, Hansson GK. Polyclonal origin of lymphocytes-T in human atherosclerotic plaques. Lab Invest 1991; 65:654-60.
12. Weis M, von Scheidt W.Cardiac allograft vasculopathy:A review. Circulation 1997; 96:2069-77.
13. Nieto FJ. Infections and atherosclerosis: New clues from an old hypothesis? Am J Epidemiol 1998;148:937-48.
14. Fabricant CG, Fabricant J, Litrenta MM, Minick CR.Virus-indueed atherosclerosis, J Exp Med 1978;148:335-40.
15. Capron L. Virus et athérosclérose. Rev Prat 1990:40: 2227-33.
16. Capron L.Wyplosz B. Thèoríe infectieuse de l'athérosclérose.Arch Mal Cœur 1998; 91 (suppl.V):21-6.
17. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniæ antibodies, cardiovascular events, and azíthromycin in male survïvors of myocardial infarction.Circulation 1997;96:404-7.
18. Gurfinkel E, Boiovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomised trial of roxithromycin in non-Q wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
19. Mäkeiä PH. Is cardiovascular disease preventable by vaccination? Ann Med 1999; 31:61-5.
20. Kol A, Libby P.The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trend Cardiovasc Med 1998;8:191-9.